Search for other papers by David S McLaren in
Google Scholar
PubMed
Search for other papers by Aarani Devi in
Google Scholar
PubMed
Search for other papers by Nikolaos Kyriakakis in
Google Scholar
PubMed
Search for other papers by Michelle Kwok-Williams in
Google Scholar
PubMed
Division of Cardiovascular and Diabetes Research, Leeds Institute of Cardiovascular and Metabolic Medicine (LICAMM), University of Leeds, Leeds, UK
Search for other papers by Robert D Murray in
Google Scholar
PubMed
many childhood cancers requiring radiation therapy to induce remission. Current data support at least the equivalence of PBT to photon-based therapies in terms of recurrence-free survival and overall survival. Although the dosimetric studies are
Institut Cochin, INSERM U1016, CNRS UMR8104, Université Paris Descartes, Sorbonne Paris Cité, Paris, France
Search for other papers by Anne Jouinot in
Google Scholar
PubMed
Search for other papers by Bernard Royer in
Google Scholar
PubMed
Search for other papers by Etienne Chatelut in
Google Scholar
PubMed
Search for other papers by Sotheara Moeung in
Google Scholar
PubMed
Department of Endocrinology, Center for Rare Adrenal Diseases, Hôpital Cochin, Assistance Publique Hôpitaux de Paris, Paris, France
Search for other papers by Guillaume Assié in
Google Scholar
PubMed
Pharmacokinetics and Pharmacochemistry Unit, Cochin Hospital, Paris Descartes University, AP-HP, Paris, France
Search for other papers by Audrey Thomas-Schoemann in
Google Scholar
PubMed
Department of Endocrinology, Center for Rare Adrenal Diseases, Hôpital Cochin, Assistance Publique Hôpitaux de Paris, Paris, France
Search for other papers by Jérôme Bertherat in
Google Scholar
PubMed
Search for other papers by François Goldwasser in
Google Scholar
PubMed
UMR8638 CNRS, Pharmacy UFR, University of Paris Descartes, PRES sorbonne Paris Cité, Paris, France
Search for other papers by Benoit Blanchet in
Google Scholar
PubMed
progression-free survival (5 months) remain disappointing. Furthermore, lower rates of severe hematological toxicities are observed with EDP-mitotane regimen than with platinum-etoposide in small-cell lung cancer (SCLC) patients (11 vs 53% of grade 3
Search for other papers by Magdalena Lech in
Google Scholar
PubMed
Search for other papers by Ruvini Ranasinghe in
Google Scholar
PubMed
Faculty of Life Sciences and Medicine, School of Life Course Sciences, King’s College London, London, UK
Search for other papers by Royce P Vincent in
Google Scholar
PubMed
Search for other papers by David R Taylor in
Google Scholar
PubMed
Search for other papers by Lea Ghataore in
Google Scholar
PubMed
Search for other papers by James Luxton in
Google Scholar
PubMed
Quebec Heart and Lung Institute, Laval University, Quebec, Canada
Search for other papers by Fannie Lajeunesse-Trempe in
Google Scholar
PubMed
Search for other papers by Pia Roser in
Google Scholar
PubMed
Search for other papers by Eftychia E Drakou in
Google Scholar
PubMed
Search for other papers by Ling Ling Chuah in
Google Scholar
PubMed
Barts and the London School of Medicine, Centre for Endocrinology, William Harvey Institute, London, UK
Neuroendocrine Tumour Unit, Royal Free Hospital, London, UK
Search for other papers by Ashley B Grossman in
Google Scholar
PubMed
Search for other papers by Simon J B Aylwin in
Google Scholar
PubMed
Obesity, Type 2 Diabetes and Immunometabolism Research Group, School of Cardiovascular and Metabolic Medicine & Sciences, Faculty of Life Course Sciences, King’s College London, London, UK
Division of Reproductive Health, Warwick Medical School, University of Warwick, Coventry, UK
Search for other papers by Georgios K Dimitriadis in
Google Scholar
PubMed
frequently reported are generalised symptoms of cancer such as cachexia, night sweats and fever ( 3 ). The prognosis of ACC is generally poor, with a median overall survival of 3–4 years ( 2 ). Currently, the only curative treatment is surgery. The current
West Cancer Center, Memphis, Tennessee, USA
Search for other papers by Michael Ulm in
Google Scholar
PubMed
Search for other papers by Arvind V Ramesh in
Google Scholar
PubMed
Search for other papers by Keely M McNamara in
Google Scholar
PubMed
Search for other papers by Suriyan Ponnusamy in
Google Scholar
PubMed
Search for other papers by Hironobu Sasano in
Google Scholar
PubMed
West Cancer Center, Memphis, Tennessee, USA
Search for other papers by Ramesh Narayanan in
Google Scholar
PubMed
therapeutics to treat these cancers has substantially increased. These new treatment options, though extended the progression-free and overall survival, have also contributed to more resistant and aggressive disease variants. For example, although undisputedly
Search for other papers by Thera P Links in
Google Scholar
PubMed
Search for other papers by Trynke van der Boom in
Google Scholar
PubMed
Search for other papers by Wouter T Zandee in
Google Scholar
PubMed
Search for other papers by Joop D Lefrandt in
Google Scholar
PubMed
and higher prevalence of cervical lymph nodes and distant (mostly pulmonary) metastases, and show a higher recurrence rate compared to adults ( 27 , 28 ). Nevertheless, their prognosis is even better than that of adults, with 15-year survival rates
Search for other papers by C Sui in
Google Scholar
PubMed
Search for other papers by Q He in
Google Scholar
PubMed
Search for other papers by R Du in
Google Scholar
PubMed
Search for other papers by D Zhang in
Google Scholar
PubMed
Search for other papers by F Li in
Google Scholar
PubMed
Search for other papers by G Dionigi in
Google Scholar
PubMed
Search for other papers by N Liang in
Google Scholar
PubMed
Search for other papers by H Sun in
Google Scholar
PubMed
-specific mortality; DSM, disease-specific mortality; DSS, disease-specific survival; EFS, event free survival; LNs, lymph nodes; Location of positive LNs, N1a and N1b; NR, lymph node ratio; OS, overall survival. In the current study, we examined the
1st Department of Propaupaedic Internal Medicine, Endocrine Unit, Laiko Hospital, National and Kapodistrian University of Athens, Athens, Greece
Search for other papers by Kosmas Daskalakis in
Google Scholar
PubMed
Search for other papers by Marina Tsoli in
Google Scholar
PubMed
Search for other papers by Anna Angelousi in
Google Scholar
PubMed
Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, Athens, Greece
Search for other papers by Evanthia Kassi in
Google Scholar
PubMed
Search for other papers by Krystallenia I Alexandraki in
Google Scholar
PubMed
Search for other papers by Denise Kolomodi in
Google Scholar
PubMed
Clinical Sciences Research Laboratories, Warwick Medical School, University of Warwick, University Hospital, Coventry, UK
Centre of Applied Biological & Exercise Sciences, Faculty of Health & Life Sciences, Coventry University, Coventry, UK
Search for other papers by Gregory Kaltsas in
Google Scholar
PubMed
Search for other papers by Anna Koumarianou in
Google Scholar
PubMed
index (KI67) ( 7 , 8 ). Everolimus interacts with the MTOR pathway and related intracellular pathways, suppressing downstream multi-protein complexes and increasing progression-free survival (PFS) across different sets of NENs ( 9 , 10 , 6 , 3 ). On
Search for other papers by Emily Warmington in
Google Scholar
PubMed
Search for other papers by Gabrielle Smith in
Google Scholar
PubMed
Search for other papers by Vasileios Chortis in
Google Scholar
PubMed
Department of Neurosurgery, Technical University Munich (TMU), Munich, Germany
Search for other papers by Raimunde Liang in
Google Scholar
PubMed
Search for other papers by Juliane Lippert in
Google Scholar
PubMed
Search for other papers by Sonja Steinhauer in
Google Scholar
PubMed
Search for other papers by Laura-Sophie Landwehr in
Google Scholar
PubMed
Medizinische Klinik Und Poliklinik III, University Hospital Carl Gustav Carus, Dresden, Germany
Search for other papers by Constanze Hantel in
Google Scholar
PubMed
Search for other papers by Katja Kiseljak-Vassiliades in
Google Scholar
PubMed
Search for other papers by Margaret E Wierman in
Google Scholar
PubMed
Search for other papers by Barbara Altieri in
Google Scholar
PubMed
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
Search for other papers by Paul A Foster in
Google Scholar
PubMed
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
Search for other papers by Cristina L Ronchi in
Google Scholar
PubMed
of patients; R0, complete resection; R1, microscopic incomplete resection; R2, macroscopic incomplete resection; RX, uncertain resection. The clinical outcome of patients with ACC was assessed by overall survival (OS) and progression-free
Structural and Functional Biology Program, Universidade Federal de São Paulo, São Paulo, Brazil
Search for other papers by Erika Urbano Lima in
Google Scholar
PubMed
Structural and Functional Biology Program, Universidade Federal de São Paulo, São Paulo, Brazil
Search for other papers by Ileana G S Rubio in
Google Scholar
PubMed
Post-graduate Program in Interactive Processes of Organs and Systems, Health & Science Institute, Federal University of Bahia, Salvador, Brazil
Search for other papers by Joaquim Custodio Da Silva in
Google Scholar
PubMed
Search for other papers by Ana Luiza Galrão in
Google Scholar
PubMed
Post-graduate Program in Interactive Processes of Organs and Systems, Health & Science Institute, Federal University of Bahia, Salvador, Brazil
Search for other papers by Danielle Pêssoa in
Google Scholar
PubMed
Search for other papers by Taise Cerqueira Oliveira in
Google Scholar
PubMed
Post-graduate Program in Interactive Processes of Organs and Systems, Health & Science Institute, Federal University of Bahia, Salvador, Brazil
Search for other papers by Fabiane Carrijo in
Google Scholar
PubMed
Search for other papers by Igor Silva Campos in
Google Scholar
PubMed
Department of Anatomic Pathology & Legal Medicine, Bahia Federal Medical School, Federal University of Bahia, Salvador, Brazil
Search for other papers by Luciano Fonseca Espinheira in
Google Scholar
PubMed
Search for other papers by Luiz Jose Sampaio in
Google Scholar
PubMed
Search for other papers by Claudio Rogerio Lima in
Google Scholar
PubMed
Division of Genetics, Department of Morphology and Genetics, Genetic Basis of Thyroid Tumors Laboratory, Paulista School of Medicine, Universidade Federal de São Paulo, São Paulo, Brazil
Search for other papers by Janete Maria Cerutti in
Google Scholar
PubMed
Post-graduate Program in Interactive Processes of Organs and Systems, Health & Science Institute, Federal University of Bahia, Salvador, Brazil
Search for other papers by Helton Estrela Ramos in
Google Scholar
PubMed
-methylation correlated with older age (≥45 years) ( P < 0.001) and with follicular variant ( P = 0.002). Kaplan–Meier survival analysis showed significant association of hyper-methylation with worse overall survival ( P = 0.003), worse disease free status ( P = 0
Centre for Endocrinology, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK
Search for other papers by Nicola Tufton in
Google Scholar
PubMed
Department of Paediatric Endocrinology, Royal London Hospital, Barts Health NHS Trust, London, UK
Search for other papers by Lucy Shapiro in
Google Scholar
PubMed
Search for other papers by Anju Sahdev in
Google Scholar
PubMed
Search for other papers by Ajith V Kumar in
Google Scholar
PubMed
Search for other papers by Lee Martin in
Google Scholar
PubMed
Centre for Endocrinology, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK
Search for other papers by William M Drake in
Google Scholar
PubMed
Centre for Endocrinology, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK
Search for other papers by Scott A Akker in
Google Scholar
PubMed
Department of Paediatric Endocrinology, Royal London Hospital, Barts Health NHS Trust, London, UK
Search for other papers by Helen L Storr in
Google Scholar
PubMed
. Urine metanephrine:creatinine ratio was measured on spot urine samples. Plasma metanephrines (free fractionated) were analysed by LC-MS/MS. Age-specific reference ranges were used for spot urine metanephrine:creatinine ratio and plasma metanephrine